ArticleBiophysical journal2026
Chaperone proteins protect against desmin fragment amyloid aggregation.
Article in Biophysical journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
- Erratum issued
Authors and funding
2 authors.
Funding
Abstract
In desmin-related cardiomyopathy, cellular stresses cause desmin to cleave and aggregate in vivo. Cleaved desmin fragments are amyloidogenic and induce misfolding, aggregation, and amyloid fibril formation of full-length wild-type desmin. Alongside this disease condition, cells overexpress αB-crystallin and heat shock protein (HSP) 27 as cardioprotective chaperones. Chaperone proteins may refold, sequester, or disaggregate misfolded or aggregating client proteins. Previously, little was known about the protective influence of chaperone proteins on desmin fragment amyloid formation. Here, we studied the secondary structure changes, kinetics, and morphology of desmin fragment amyloid formation with and without chaperone proteins αB-crystallin and HSP27. We found that both of these proteins prevent or delay amyloid formation in a concentration-dependent manner, but we did not observe amyloid disaggregation. We discovered better chaperone activity by αB-crystallin than HSP27 toward desmin fragment, correlated to increased binding sites between αB-crystallin and desmin fragment. Our interaction studies demonstrated that monomers or amorphous oligomers were likely reversibly captured by these chaperone proteins, whereas desmin fragment amyloid fibrils were likely irreversibly capped by chaperone proteins. Overall, αB-crystallin and HSP27 recognized and interacted with both desmin fragment monomer and desmin fragment amyloid at distinct sites to prevent further amyloid formation.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.